PELP1 and AIB1 cooperate to promote breast cancer progression in ER plus breast cancer models.

被引：0
|
作者：
Truong, Thu H. [1 ]
Hu, Hsiangyu [1 ]
Ostrander, Julie H. [1 ]
Lange, Carol A. [1 ]
机构：
[1] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
来源：
MOLECULAR CANCER RESEARCH | 2018年 / 16卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A30
引用
收藏
页码：40 / 41
页数：2
相关论文
共 50 条
  • [21] Characterization of small molecule inhibitors of PELP1 for treating advanced breast cancer
    Altwegg, Kristin Ann
    Viswanadhapalli, Suryavathi
    Mann, Monica
    Pratap, Uday P.
    Li, Mengxing
    Liu, Junhao
    Luo, Yiliao
    Sareddy, Gangadhara R.
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2020, 80 (16)
  • [22] AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
    Anzick, SL
    Kononen, J
    Walker, RL
    Azorsa, DO
    Tanner, MM
    Guan, XY
    Sauter, G
    Kallioniemi, OP
    Trent, JM
    Meltzer, PS
    SCIENCE, 1997, 277 (5328) : 965 - 968
  • [23] Polymorphic repeat in AIB1 does not alter breast cancer risk
    Christopher A Haiman
    Susan E Hankinson
    Donna Spiegelman
    Graham A Colditz
    Walter C Willett
    Frank E Speizer
    Myles Brown
    David J Hunter
    Breast Cancer Research, 2
  • [24] AIB1 reproductive risk factors, and breast cancer risk.
    Terry, MB
    Zhang, FF
    Senie, R
    Shen, J
    Santella, R
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2004, 13 (11) : 1896S - 1896S
  • [25] Polymorphic repeat in AIB1 does not alter breast cancer risk
    Haiman, CA
    Hankinson, SE
    Spiegelman, D
    Colditz, GA
    Willett, WC
    Speizer, FE
    Brown, M
    Hunter, DJ
    BREAST CANCER RESEARCH, 2000, 2 (05) : 378 - 385
  • [26] Somatic gene alteration of AIB1 gene in patients with breast cancer
    Shibata, A
    Hayashi, Y
    Imai, T
    Funahashi, H
    Nakao, A
    Seo, H
    ENDOCRINE JOURNAL, 2001, 48 (02) : 199 - 204
  • [27] Functional implications of altered subcellular localization of PELP1 in breast cancer cells
    Vadlamudi, RK
    Manavathi, B
    Balasenthil, S
    Nair, SS
    Yang, ZB
    Sahin, AA
    Kumar, R
    CANCER RESEARCH, 2005, 65 (17) : 7724 - 7732
  • [28] Targeting the PELP1 axis for treating ESR1 mutant driven breast cancer
    Altwegg, Kristin A.
    Viswanadhapalli, Suryavathi
    Liu, Junhao
    Liu, Zexuan
    Pratap, Uday P.
    Ebrahimi, Benham
    Vankayalapati, Hariprasad
    Vadlamudi, Ratna K.
    CANCER RESEARCH, 2021, 81 (04)
  • [29] PELP-1 promotes adverse endocrine therapy response in ER plus breast cancer
    Rees, Michael
    Smith, Chris
    Barrett-Lee, Peter
    Hiscox, Stephen
    CANCER RESEARCH, 2018, 78 (13)
  • [30] SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
    Liu, Zexuan
    Liu, Junhao
    Ebrahimi, Behnam
    Pratap, Uday P.
    He, Yi
    Altwegg, Kristin A.
    Tang, Weiwei
    Li, Xiaonan
    Lai, Zhao
    Chen, Yidong
    Shen, Liangfang
    Sareddy, Gangadhara R.
    Viswanadhapalli, Suryavathi
    Tekmal, Rajeshwar R.
    Rao, Manjeet K.
    Vadlamudi, Ratna K.
    BREAST CANCER RESEARCH, 2022, 24 (01)
12345